Latest Schedule 13G passive stakes

Pershing Square Management, LLC and Pershing Square Partner Group, LLC disclose combined beneficial ownership of 300,268,979 shares, representing 75.1% of Pershing Square Inc.'s common stock.

Millennium Management LLC, along with affiliated entities and Israel A. Englander, has reported beneficial ownership of 456,706 shares, representing 0.5% of Factorial Energy Inc.'s Series A Common Stock.

Ryan Israel has filed a Schedule 13G, reporting beneficial ownership of 31,099,877 shares, representing 7.8% of Pershing Square Inc.'s common stock.

ERock, Inc. files Schedule 13G detailing significant beneficial ownership changes by Walter Thomas McAndrew Jr. and associated entities.

Sprott Inc. and its subsidiary Sprott Asset Management USA Inc. have filed an amendment to their Schedule 13G, reporting their beneficial ownership of i-80 Gold Corp. common shares.

Sprott Inc. and its subsidiary Sprott Asset Management USA Inc. have filed an amendment to their Schedule 13G, reporting their beneficial ownership of i-80 Gold Corp. common shares.

Madison Dearborn Partners LLC and its affiliates have reported beneficial ownership of 49.5% of AEVEX Corp.'s Class A common stock, including shares issuable upon conversion of Series B Units.

William Ackman and WAA Management LLC report combined beneficial ownership of over 181 million shares, representing 45.3% of Pershing Square Inc.'s common stock.

Multiple Founders Fund entities and Peter Thiel have entered into a joint filing agreement to collectively report their beneficial ownership of Space Exploration Technologies Corp. Class A common stock.

OrbiMed Advisors LLC and OrbiMed Genesis GP LLC have jointly reported beneficial ownership of 7.3% of Whitehawk Therapeutics, Inc. common stock as of June 30, 2026.

Vyacheslav Kim has updated his beneficial ownership filing for Kaspi.kz, reporting a slight decrease in his stake to 19.7% as of the filing date.

Kenneth Bryan Dart, through Candle Lake Limited, has reported beneficial ownership of 28,581,386 ordinary shares, representing 5.8% of DraftKings Inc.'s Class A shares.

An amendment to Schedule 13G details significant beneficial ownership changes for BrightSpire Capital, Inc. Class A Common Stock.

An amendment to Schedule 13G details updated beneficial ownership of CoreWeave Inc. Class A Common Stock by Michael N. Intrator and related entities.

OrbiMed Advisors LLC and OrbiMed Capital LLC have filed an amendment reporting zero shares beneficially owned in Vistagen Therapeutics, Inc.

OrbiMed Advisors LLC and OrbiMed Capital LLC have jointly filed a Schedule 13G, disclosing their beneficial ownership of Spruce Biosciences, Inc. common stock.

Millennium Management LLC, along with affiliated entities and Israel A. Englander, have filed a Schedule 13G detailing their beneficial ownership of Enhanced Group Inc. Class A Common Stock.

An amended Schedule 13G filing reveals significant beneficial ownership of TWFG, Inc. Class A Common Stock by Richard F. Bunch III, Michelle Caroline Bunch, and Bunch Family Holdings, LLC.

OrbiMed Advisors LLC and OrbiMed Capital GP VI LLC collectively report a 4.4% ownership in NeuroPace, Inc. common stock as of June 30, 2026.

Barclays PLC has disclosed beneficial ownership of 273,125 shares, representing 6.74% of the outstanding common stock in Rising Dragon Acquisition Co.

Barclays PLC has disclosed beneficial ownership of 273,125 shares, representing 6.74% of the outstanding common stock in Rising Dragon Acquisition Co.

CoreWeave, Inc. has filed an Amendment No. 2 to its Schedule 13G, marking a final exit filing for the reporting persons.

OrbiMed Advisors LLC and OrbiMed Capital LLC have jointly filed a Schedule 13G, reporting beneficial ownership of 4.1% and 1.0% respectively in Lexeo Therapeutics, Inc.

BK Technologies Corp filing indicates Breach Inlet Capital Management, LLC and affiliated entities now beneficially own 6.6% of the company's common stock.

Clear Street LLC has reported beneficial ownership of 12.9% of Integrated Wellness Acquisition Corp's common stock as of June 30, 2026.

Clear Street LLC has reported beneficial ownership of 410,358 shares, representing 7.6% of the outstanding common stock of Canna-Global Acquisition Corp as of June 30, 2026.

OrbiMed Advisors LLC, OrbiMed Genesis GP LLC, and OrbiMed Capital LLC have filed a Schedule 13G, reporting beneficial ownership of Immunic, Inc. common stock.

BeyondSpring Inc. has filed an amendment to its Schedule 13G, detailing changes in beneficial ownership among key reporting persons.

Clear Street LLC has reported beneficial ownership of 308,923 shares, representing 5.0% of the common stock of StoneBridge Acquisition II Corporation as of June 30, 2026.

An amendment to Schedule 13G has been filed for CoreWeave, Inc., detailing updated beneficial ownership percentages for key individuals and trusts as of June 30, 2026.